Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to the newest version of your browser.

Your browser appears to have cookies disabled. For the best experience of Construction News, please enable cookies in your browser.

Welcome to the Construction News site. As we have relaunched, you will have to sign in once now and agree for us to use cookies, so you won't need to log in each time you visit our site.
Learn more


Laing Management and Morrison Knudsen have again teamed up to build an £80 million process plant and laboratory development for pharmaceuticals giant SmithKline Beecham (SB).Called LMK, the joint venture's management contract is for SB's science complex at Harlow in Essex, where total investment on the site could top £200 million.Laing said tendering would start during the summer, with foundation works for the main lab complex starting in October. Total construction time is expected to be 22 months.The construction of a biotechnology pilot plant and research laboratories with a total floorspace of around 45,000 sq m effectively concentrates SB's research and development facilities on three sites from the current seven.LMK is gaining a track record in the management of cutting-edge technological projects.It won the project management contract to sort out the troubled £450 million Glaxo research campus site at Stevenage in Hertfordshire.Meanwhile, SB has received outline planning permission to redevelop its 6 ha corporate headquarters site at Brentford in west London.A spokesman said: 'We've received a number of suggestions from architects about what we could do with the site, but no firm decisions have been taken.' CONSTRUCTION NEWS

Related Jobs